|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 20719 |
FusionGeneSummary for MAML3_POU3F2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MAML3_POU3F2 | Fusion gene ID: 20719 | Hgene | Tgene | Gene symbol | MAML3 | POU3F2 | Gene ID | 55534 | 5454 |
| Gene name | mastermind like transcriptional coactivator 3 | POU class 3 homeobox 2 | |
| Synonyms | CAGH3|ERDA3|GDN|MAM-2|MAM2|TNRC3|mam-3 | BRN2|N-Oct3|OCT7|OTF-7|OTF7|POUF3|brn-2|oct-7 | |
| Cytomap | 4q31.1 | 6q16.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | mastermind-like protein 3CAG repeat containing (glia-derived nexin I alpha)expanded repeat domain, CAG/CTG 3polyglutamine richtrinucleotide repeat containing 3 | POU domain, class 3, transcription factor 2brain-2brain-specific homeobox/POU domain protein 2nervous system-specific octamer-binding transcription factor N-Oct-3octamer-binding protein 7octamer-binding transcription factor 7 | |
| Modification date | 20180524 | 20180519 | |
| UniProtAcc | Q96JK9 | P20265 | |
| Ensembl transtripts involved in fusion gene | ENST00000509479, ENST00000327122, ENST00000398940, | ENST00000328345, | |
| Fusion gene scores | * DoF score | 14 X 7 X 6=588 | 1 X 1 X 1=1 |
| # samples | 14 | 1 | |
| ** MAII score | log2(14/588*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: MAML3 [Title/Abstract] AND POU3F2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MAML3 | GO:0007219 | Notch signaling pathway | 12370315 |
| Hgene | MAML3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 12370315 |
| Tgene | POU3F2 | GO:0008284 | positive regulation of cell proliferation | 15024079 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF127989 | MAML3 | chr4 | 140811058 | - | POU3F2 | chr6 | 99283155 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000509479 | ENST00000328345 | MAML3 | chr4 | 140811058 | - | POU3F2 | chr6 | 99283155 | + |
| intron-3CDS | ENST00000327122 | ENST00000328345 | MAML3 | chr4 | 140811058 | - | POU3F2 | chr6 | 99283155 | + |
| intron-3CDS | ENST00000398940 | ENST00000328345 | MAML3 | chr4 | 140811058 | - | POU3F2 | chr6 | 99283155 | + |
Top |
FusionProtFeatures for MAML3_POU3F2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MAML3 | POU3F2 |
| Acts as a transcriptional coactivator for NOTCHproteins. Has been shown to amplify NOTCH-induced transcription ofHES1. {ECO:0000269|PubMed:12370315, ECO:0000269|PubMed:12386158}. | Transcription factor that plays a key role in neuronaldifferentiation (By similarity). Binds preferentially to therecognition sequence which consists of two distinct half-sites,('GCAT') and ('TAAT'), separated by a non-conserved spacer regionof 0, 2, or 3 nucleotides (By similarity). The combination ofthree transcription factors, ASCL1, POU3F2/BRN2 and MYT1L, issufficient to reprogram fibroblasts and other somatic cells intoinduced neuronal (iN) cells in vitro. Acts downstream of ASCL1,accessing chromatin that has been opened by ASCL1, and promotestranscription of neuronal genes (By similarity).{ECO:0000250|UniProtKB:P31360, ECO:0000250|UniProtKB:P56222}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MAML3_POU3F2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MAML3_POU3F2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MAML3_POU3F2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MAML3_POU3F2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | MAML3 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Hgene | MAML3 | C0018798 | Congenital Heart Defects | 1 | CTD_human |
| Hgene | MAML3 | C1261473 | Sarcoma | 1 | CTD_human |
| Hgene | MAML3 | C1710096 | Sinonasal undifferentiated carcinoma | 1 | CTD_human |
| Tgene | POU3F2 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|